Preclinical evaluation of FAP-2286, a peptide-targeted radionuclide therapy (PTRT) to fibroblast activation protein alpha (FAP)

被引：13
|
作者：
Zboralski, D. [1 ]
Osterkamp, F. [2 ]
Simmons, A. D. [3 ]
Bredenbeck, A. [4 ]
Schumann, A. [4 ]
Paschke, M. [5 ]
Beindorff, N. [6 ]
Mohan, A-M. [7 ]
Nguyen, M. [3 ]
Xiao, J. [8 ,9 ]
Harding, T. C. [3 ]
Hoehne, A. [10 ]
Reineke, U. [11 ]
Smerling, C. [12 ]
机构：
[1] 3B Pharmaceut GmbH, Assay Unit, Berlin, Germany
[2] 3B Pharmaceut GmbH, Chem & Analyt, Berlin, Germany
[3] Clovis Oncol Inc, Translat Med, Boulder, CO USA
[4] 3B Pharmaceut GmbH, Nucl Med, Berlin, Germany
[5] 3B Pharmaceut GmbH, Biol & Assay Dev, Berlin, Germany
[6] Charite Univ Med Berlin, Berlin Expt Radionuclide Imaging Ctr BERIC, Berlin, Germany
[7] Charite Univ Med Berlin, Dept Nucl Med, Berlin, Germany
[8] Clovis Oncol Inc, Clin Pharmacol, Boulder, CO USA
[9] Clovis Oncol Inc, DMPK, Boulder, CO USA
[10] 3B Pharmaceut GmbH, Radiopharmaceut Technol, Berlin, Germany
[11] 3B Pharmaceut GmbH, Berlin, Germany
[12] 3B Pharmaceut GmbH, Nucl Med & Imaging, Berlin, Germany
来源：
ANNALS OF ONCOLOGY | 2020年 / 31卷
关键词：
D O I：
10.1016/j.annonc.2020.08.685
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
571P
引用
收藏
页码：S488 / S488
页数：1
相关论文
共 50 条
  • [11] Initial experience with 177Lu-FAP-2286 peptide targeted radionuclide therapy in advanced solid tumors
    Malasani, V.
    Dash, S.
    Hari, V.
    Raj, A.
    Parwan, D.
    Singhal, N.
    Chaudhuri, S.
    Pendharkar, D.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S35 - S36
  • [12] Feasibility, Biodistribution, and Preliminary Dosimetry in Peptide-Targeted Radionuclide Therapy of Diverse Adenocarcinomas Using 177Lu-FAP-2286: First-in-Humans Results
    Baum, Richard P.
    Schuchardt, Christiane
    Singh, Aviral
    Chantadisai, Maythinee
    Robiller, Franz C.
    Zhang, Jingjing
    Mueller, Dirk
    Eismant, Alexander
    Almaguel, Frankis
    Zboralski, Dirk
    Osterkamp, Frank
    Hoehne, Aileen
    Reineke, Ulrich
    Smerling, Christiane
    Kulkarni, Harshad R.
    JOURNAL OF NUCLEAR MEDICINE, 2022, 63 (03) : 415 - 423
  • [13] Novel Co-culture Model of Pancreatic Cancer to Accurately Predict the Efficacy of Fibroblast Activation Protein Targeted Radionuclide Therapy using [161Tb]Tb-FAP-2286 and [177Lu]Lu-FAP-2286
    van der Heide, C. D.
    Lak, A.
    McMorrow, R.
    Mezzanotte, L.
    Dalm, S. U.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S187 - S188
  • [14] Preclinical evaluation of [13xLa]La-FAP-2286 as a novel theranostic agent for tumors expressing fibroblast activation protein
    Shirpour, Ali
    Hadadi, Asghar
    Zolghadri, Samaneh
    Vosoughi, Sara
    Rajabifar, Saeed
    SCIENTIFIC REPORTS, 2025, 15 (01):
  • [15] Radioligand Therapy in GBM: Fibroblast Activation Protein (FAP) Promises
    Jeanjean, P.
    Kwock, S.
    Cloughesy, T.
    Calais, J.
    Czernin, J.
    Carlucci, G.
    Nathanson, D.
    Mona, C.
    Besserer-Offroy, E.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S188 - S188
  • [16] Fibroblast activation protein alpha (FAP): targeting the reactive stroma as a novel prodrug therapy for cancer
    Brennen, W. Nathaniel
    Rosen, D. Marc
    Denmeade, Samuel R.
    CLINICAL & EXPERIMENTAL METASTASIS, 2011, 28 (02) : 206 - 206
  • [17] Targeting Fibroblast Activation Protein: Radiosynthesis and Preclinical Evaluation of an 18F-Labeled FAP Inhibitor
    Toms, Johannes
    Kogler, Juergen
    Maschauer, Simone
    Daniel, Christoph
    Schmidkonz, Christian
    Kuwert, Torsten
    Prante, Olaf
    JOURNAL OF NUCLEAR MEDICINE, 2020, 61 (12) : 1806 - 1813
  • [18] Preclinical Evaluation of 68Ga/177Lu labeled novel FAP-targeted peptide for tumor radionuclide imaging and therapy
    Wang, Weichen
    Wang, Rang
    Huang, MingXing
    Tian, Rong
    JOURNAL OF NUCLEAR MEDICINE, 2024, 65
  • [19] Autophagy inhibition improves the targeted radionuclide therapy efficacy of 131I-FAP-2286 in pancreatic cancer xenografts
    Liu, Xingyu
    Li, Danni
    Ma, Tianbao
    Luo, Xiu
    Peng, Ye
    Wang, Tao
    Zuo, Changjing
    Cai, Jianming
    JOURNAL OF TRANSLATIONAL MEDICINE, 2024, 22 (01)
  • [20] Autophagy inhibition improves the targeted radionuclide therapy efficacy of 131I-FAP-2286 in pancreatic cancer xenografts
    Xingyu Liu
    Danni Li
    Tianbao Ma
    Xiu Luo
    Ye Peng
    Tao Wang
    Changjing Zuo
    Jianming Cai
    Journal of Translational Medicine, 22
12345